MedTrace Logo

Determination of Optimum Time for Intravenous Cannulation in Children With Dexmedetomidine Premedication

NCT05139212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-02-07

No results posted yet for this study

Summary

Inhalational induction with sevoflurane, nitrous oxide, and oxygen is accepted as a safe technique to avoid any movement during intravenous cannulation in children. In addition, intranasal dexmedetomidine could be used for premedication to reduce preoperative anxiety in preschool children. Early attempts to place, an intravenous line may result in movement and respiratory complications like coughing or laryngospasm. On the other hand delay in cannulation may prevent effective management of bradycardia and hypotension. There are a number of studies examining the optimum time for cannulation after sevoflurane induction. However, it is not known whether the addition of dexmedetomidine premedication affects the time for intravenous cannulation following induction with sevoflurane and nitrous oxide.

Conditions

  • Cannulation
  • Sevoflurane Induction
  • Dexmedetomidine

Interventions

PROCEDURE

Optimum time for intravenous cannulation in children premedicated with dexmedetomidine

The optimum time for intravenous cannulation after the induction of anesthesia with sevoflurane, oxygen, and nitrous oxide in children with intranasal dexmedetomidine premedication will be searched in children undergoing elective surgery.

Sponsors & Collaborators

  • Karaman Training and Research Hospital

    lead OTHER

Principal Investigators

  • Rafet Yarimoglu, MD · Karaman Training and Research Hospital

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-02
Primary Completion
2022-02-04
Completion
2022-02-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05139212 on ClinicalTrials.gov